BNP Paribas analyst Chris Bottiglieri reiterated an 'Underperform' rating on Petco Health and Wellness and reduced its price target from $2.34 to $2.11. This adjustment signals a continued bearish outlook on the company's stock performance, potentially influencing investor sentiment negatively.
BNP Paribas analyst Chris Bottiglieri has maintained an 'Underperform' rating on Petco Health and Wellness (WOOF) and lowered the price target from $2.34 to $2.11. This action indicates a continued lack of confidence in the company's future performance by a notable financial institution. The lowered price target suggests that BNP Paribas sees further downside risk or limited upside potential for WOOF shares, affecting current and potential investors. In the short term, this could lead to negative pressure on WOOF's stock price as investors react to the analyst's revised outlook. Long-term implications depend on whether Petco can address the underlying issues that led to this bearish sentiment, but for now, it presents a key risk for traders holding or considering positions in WOOF.